Latest Innovation News

GoldArc Resources has secured a strategic partnership with BML Ventures to fast-track the Mt Stirling Project, backed by a $2.5 million non-dilutive funding facility that supports both development and broader exploration.

Ardea Resources updates its Definitive Feasibility Study for the Kalgoorlie Nickel Project, confirming a streamlined processing approach and a new sale product that could enhance project economics and market reach.

Anson Resources' subsidiary A1 Lithium has signed a non-binding MoU with Nusano to supply high-purity lithium chloride from Utah’s Green River project for advanced nuclear isotope production. This marks a strategic step into the nuclear technology supply chain alongside ongoing electric vehicle market efforts.

DigiCo Infrastructure REIT appoints Michael Juniper as CEO, signaling a strategic push into advanced data centre development amid rising cloud and AI demand. Chris Maher shifts focus to government relations, underscoring regulatory challenges ahead.

S&P Dow Jones Indices has revealed its December 2025 quarterly rebalance, introducing notable changes across major ASX indices that could reshape market dynamics ahead of the new year.

S&P Dow Jones Indices has announced its December 2025 quarterly rebalance, introducing notable additions and removals across key S&P/ASX indices effective December 22. The reshuffle highlights shifts in market dynamics with fresh entrants and exits in major Australian stock indices.

Livium Ltd has secured a A$663,000 R&D tax rebate for its subsidiary VSPC, pushing total FY25 rebates to A$1.4 million and reinforcing its push into advanced battery materials and recycling.

Wisr Limited has successfully closed its Share Purchase Plan, raising $1.22 million and reducing corporate debt by $7.5 million as part of a broader $10.6 million capital raise.

Sparc Hydrogen has reached a pivotal milestone with sustained hydrogen generation at its Roseworthy pilot plant, advancing its innovative photocatalytic water splitting technology towards commercialisation.

Algorae Pharmaceuticals has independently validated its AI-driven drug combination platform, AlgoraeOS v1, confirming its ability to predict synergistic cancer drug pairs. The company has also launched an upgraded version, AlgoraeOS v2, poised to enhance drug discovery efforts.

Premier Investments reported a robust FY25 with a 31% rise in net profit, driven by strong performances from Peter Alexander and Smiggle, alongside a strategic capital return plan including a $100 million share buyback.

NEXTDC has inked a Memorandum of Understanding with OpenAI to develop a cutting-edge sovereign AI infrastructure in Sydney, marking a major step in Australia’s digital sovereignty ambitions.